A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia
E Archimbaud(European Union), Dieter Hoelzer(Endokrinologikum), Pierre Fenaux(Saint Louis University Hospital), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Oliver G. Ottmann(Cardiff University), Caroline O’Brien-Ewen(Goethe University Frankfurt), John A. Liu Yin(Goethe University Frankfurt), Klaus Lechner, Wolfram Brugger(University of Freiburg), James Matcham(Goethe University Frankfurt), Hervé Dombret(University of London Institute in Paris), Gerhard Heil(Goethe University Frankfurt), Alan Barge(Goethe University Frankfurt)
Cited by 119
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k